Mochida Pharmaceutical Co. Ltd

Research Mochida Pharmaceutical Co. Ltd (MFY) on Bullrun: valuation model: 8.7% undervalued, market cap EUR 595.06M, P/E 13.9, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerMFY
• ExchangeF
• CountryJapan
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Valuation signal8.7% undervalued
• Market capEUR 595.06M
• P/E13.9
• Dividend yield2.7%
• Financial periodFY2025
• RevenueEUR 105.16B
• Revenue growth2.2%
• Net incomeEUR 5.69B
• Free cash flowEUR 7.19B
• Gross margin51.1%

Valuation Snapshot

Bullrun's latest valuation model marks Mochida Pharmaceutical Co. Ltd as 8.7% undervalued; latest market cap is EUR 595.06M; P/E is 13.9; dividend yield is 2.7%.

About Mochida Pharmaceutical Co. Ltd

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the treatment of ulcerative colitis; Goofice and Movicol for the treatment of chronic constipation; Epadel for hyperlidemia and arteriosclerosis obliterans; Urece for gout and hyperuricemia;

Frequently asked questions

Is Mochida Pharmaceutical Co. Ltd overvalued or undervalued?

Bullrun's valuation model currently marks Mochida Pharmaceutical Co. Ltd as 8.7% undervalued.

What is Mochida Pharmaceutical Co. Ltd's market cap?

Mochida Pharmaceutical Co. Ltd's market capitalization is EUR 595.06M.

What is Mochida Pharmaceutical Co. Ltd's P/E ratio?

Mochida Pharmaceutical Co. Ltd's price-to-earnings (P/E) ratio is 13.9.

Does Mochida Pharmaceutical Co. Ltd pay a dividend?

Mochida Pharmaceutical Co. Ltd has a dividend yield of 2.7%.

What does Mochida Pharmaceutical Co. Ltd do?

Mochida Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and healthcare products in Japan. It offers pharmaceuticals products for the treatment of cardiovascular, obstetrics, gynecology, dermatology, psychiatry, and gastroenterology, including Lialda, Omvoh, and Cortiment for the...